BioCrude Technologies USA, Inc. Operating Expenses
BioCrude Technologies USA, Inc. reported Operating Expenses of $61.14 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-11
- BioCrude Technologies USA, Inc. operating expenses for the quarter ending 2026-06-30 was $26.71K, a 35.62% decline year-over-year.
- BioCrude Technologies USA, Inc. operating expenses for the quarter ending 2026-03-31 was $34.43K, a 40.37% decline year-over-year.
- BioCrude Technologies USA, Inc. operating expenses for the quarter ending 2025-06-30 was $41.48K.
- BioCrude Technologies USA, Inc. operating expenses for the quarter ending 2025-03-31 was $57.74K, a 52.90% decline year-over-year.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month |
|---|---|---|---|---|---|
| 2026-06-30 | $26.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $61.14K 10-Q · filed 2026-08-11 | |||
| 2026-03-31 | $34.43K 10-Q · filed 2026-05-13 | ||||
| 2025-06-30 | $41.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $99.22K 10-Q · filed 2026-08-11 | |||
| 2025-03-31 | $57.74K 10-Q · filed 2026-05-13 | ||||
| 2024-03-31 | $122.60K 10-Q · filed 2025-05-14 | ||||
| 2022-09-30 | $88.30K 10-Q · filed 2022-11-04 | $102.82K derived: sum of 2 quarters · filed 2022-11-04 | $155.87K 10-Q · filed 2022-11-04 | ||
| 2022-06-30 | $14.53K 10-Q · filed 2022-08-10 | $67.57K 10-Q · filed 2022-08-10 | |||
| 2021-09-30 | $45.88K 10-Q · filed 2022-11-04 | $198.04K derived: sum of 2 quarters · filed 2022-11-04 | $360.73K 10-Q · filed 2022-11-04 | ||
| 2021-06-30 | $152.16K 10-Q · filed 2022-08-10 | $314.85K 10-Q · filed 2022-08-10 | |||
| 2020-09-30 | $59.51K 10-Q · filed 2021-11-08 | $81.46K derived: sum of 2 quarters · filed 2021-11-08 | $101.90K 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | $21.95K 10-Q · filed 2021-08-02 | $42.40K 10-Q · filed 2021-08-02 | |||
| 2019-09-30 | $54.76K 10-Q · filed 2020-11-10 | $56.76K 10-Q · filed 2019-11-13 | $101.82K derived: sum of 2 quarters · filed 2020-11-10 | $156.12K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $47.05K 10-Q · filed 2020-08-10 | $101.36K 10-Q · filed 2020-08-10 | |||
| 2018-09-30 | $57.80K 10-Q · filed 2019-11-13 | $84.66K derived: sum of 2 quarters · filed 2019-11-13 | $852.12K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $26.87K 10-Q · filed 2019-08-12 | $794.32K 10-Q · filed 2019-08-12 | |||
| 2017-09-30 | $222.48K 10-Q · filed 2018-11-08 | $249.92K derived: sum of 2 quarters · filed 2018-11-08 | $286.55K 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $27.44K 10-Q · filed 2018-08-24 | $21.44K 10-Q · filed 2017-09-12 | $70.08K 10-Q · filed 2018-08-24 | $64.08K 10-Q · filed 2017-09-12 | |
| 2016-09-30 | $39.78K 10-Q · filed 2017-10-24 | $96.09K derived: sum of 2 quarters · filed 2017-10-24 | $137.28K 10-Q · filed 2017-10-24 | ||
| 2016-06-30 | $56.31K 10-Q · filed 2017-09-12 | $97.50K 10-Q · filed 2017-09-12 |